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Abstract
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the modification
of the terms of the authorisation of BioPlus® 2B (Bacillus licheniformis DSM 5749 and Bacillus subtilis
DSM 5750) in feeds for turkeys for fattening to allow the simultaneous use with a battery of permitted
coccidiostats (diclazuril, halofuginone, monensin sodium, robenidine hydrochloride, maduramicin
ammonium, lasalocid sodium) and with the preservative formic acid. The proposed modification in the
conditions of the authorisation would not modify the conclusions previously drawn regarding the safety
of the additive. The additive is safe for the target species, consumers and the environment. The
additive should be considered a potential respiratory sensitiser, but the Panel could not conclude on
the irritancy of the additive to skin and eyes or its dermal sensitisation. Conclusions previously drawn
by the FEEDAP Panel on the compatibility of the additive for chickens for fattening apply to the current
application provided that the maximum authorised concentration of the coccidiostats semduramycin,
maduramicin ammonium, lasalocid sodium and the preservative formic acid for turkeys for fattening
(when maximum authorised concentrations exist), are equal or lower than those for chickens for
fattening. Considering the data submitted, the FEEDAP Panel concludes that BioPlus® 2B
(B. licheniformis DSM 5749 and B. subtilis DSM 5750) is compatible with diclazuril and monensin
sodium. Based on the data provided, no conclusion can be drawn for robenidine hydrochloride. In the
absence of data, no conclusion can be drawn for halofuginone.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 13(3) of that Regulation lays down that if the
holder of an authorisation proposes changing the terms of the authorisation by submitting an
application to the Commission, accompanied by the relevant data supporting the request for the
change, the Authority shall transmit its opinion on the proposal to the Commission and the Member
States.
The European Commission received a request from Chr. Hansen A/S2 for modifications of the terms
of authorisation of the product BioPlus® 2B (Bacillus licheniformis DSM 5749 and Bacillus subtilis DSM
5750), when used as a feed additive for turkeys for fattening (category: zootechnical additives;
functional group: gut flora stabilisers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 13(3)
(modification of the authorisation of a feed additive). EFSA received directly from the applicant the
technical dossier in support of this application. The particulars and documents in support of the
application were considered valid by EFSA as of 09 October 2018.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efficacy of the
product BioPlus® 2B (Bacillus licheniformis DSM 5749 and Bacillus subtilis DSM 5750), when used
under the proposed conditions of use (Section 3.1).
1.2. Additional information
The additive BioPlus® 2B is a preparation of B. licheniformis (DSM 5749) and B. subtilis (DSM
5750). EFSA has issued several opinions on the compatibility of BioPlus® 2B with coccidiostats (EFSA,
2003, 2006, 2007b, 2008; EFSA FEEDAP Panel, 2005, 2011, 2016) and one opinion on the use of the
additive with sows (EFSA FEEDAP Panel, 2011b).
The additive is currently authorised for use in feed for pigs for fattening and piglets, sows, turkeys
for fattening and calves.3 With the current application, the applicant requests to include the
compatibility with coccidiostats and formic acid to the current authorisation for turkeys.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier4 in support of the authorisation request for the use of BioPlus® 2B (B. licheniformis DSM 5749
and B. subtilis DSM 5750) as a feed additive.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies to deliver the present output.
The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment are valid and applicable for the current
application.5
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Chr. Hansen A/S, 10-12 Boege Alle, 2970, Hoersholm, Denmark.
3 Commission Implementing Regulation (EU) 2017/447 of 14 March 2017 concerning the authorisation of the preparation of
Bacillus subtilis (DSM 5750) and Bacillus licheniformis (DSM 5749) as a feed additive for sows, weaned piglets, pigs for
fattening, calves for rearing and turkeys for fattening and amending Regulations (EC) No 1453/2004, (EC) No 2148/2004 and
(EC) No 600/2005 (holder of authorisation Chr. Hansen A/S) OJ L 69, 15.3.2017, p. 18–22. http://data.europa.eu/eli/reg_impl/
2017/447/oj
4 FEED dossier reference: FAD-2018-0061.
5 The report linked to the previous dossier (related to EFSA-Q-2008-381) is available on the EURL website: https://ec.europa.eu/
jrc/sites/jrcsh/files/FinRep-FAD-2009-0023.pdf
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2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efficacy of BioPlus® 2B
(B. licheniformis DSM 5749 and B. subtilis DSM 5750) is in line with the principles laid down in
Regulation (EC) No 429/20086 and the relevant guidance documents: Guidance on the characterisation
of microorganisms used as feed additives or as production organisms (EFSA FEEDAP Panel, 2018).
3. Assessment
The additive BioPlus 2B® is a preparation of viable spores of B. licheniformis DSM 5749 and
B. subtilis DSM 5750 intended for use in feed for turkeys for fattening (category: zootechnical
additives; functional group: gut flora stabilisers). The product has already been authorised as a
zootechnical additive (functional group: gut flora stabilisers) for use in diets and water for drinking for
several animal species, including turkeys for fattening at the dose of 1.3 9 109 colony forming units
(CFU)/kg complete feedingstuffs and 6.5 9 108 CFU/L water.7 The applicant is requesting the
modification of the terms of that authorisation to allow the simultaneous use of BioPlus® 2B in feeds
for turkeys for fattening with the permitted coccidiostats diclazuril, halofuginone, monensin sodium,
robenidine hydrochloride, maduramicin ammonium and lasalocid sodium and with formic acid.
3.1. Characterisation and conditions of use
The additive BioPlus® 2B is based on the spores of two active agents, B. licheniformis DSM 5749
and B. subtilis DSM 5750 in equal ratio at the concentration of at least 1.6 9 1010 CFU/g each on a
carrier of limestone/calcium carbonate (92.9%) and 1.1% Kieselgur (E 551c) as an anticaking agent.
The identity of the two active agents, their lack of toxigenic potential and their susceptibility to the
relevant antibiotics were established in in a previous opinion (EFSA FEEDAP Panel, 2016) in which
the additive was properly characterised. No new information has been submitted with regard to the
identity and characterisation of the additive and the Panel considers that the information previously
assessed applies to the current assessment.
BioPlus 2B® is authorised for use in feedingstuffs and water for drinking for turkeys for fattening, at
the minimum recommended level of 1.3 9 109 CFU/kg feed and 6.5 9 108 CFU/L water.
The applicant requests the modification of the current authorisation by adding the simultaneous use
of the additive in compound feed for turkeys for fattening containing (i) the authorised coccidiostats:
diclazuril, halofuginone, monensin sodium, robenidine hydrochloride, maduramicin ammonium,
lasalocid sodium and (ii) the preservative formic acid.
3.2. Safety
The bacterial species B. licheniformis and B. subtilis are considered by EFSA to be suitable for the
Qualified Presumption of Safety (QPS) approach to safety assessment (EFSA, 2007a; EFSA BIOHAZ
Panel, 2017). This approach requires the identity of the strains to be conclusively established and the
demonstration that the strains are not toxigenic and susceptible to the relevant antibiotics. The identity
of the strains and their lack of toxigenic potential and their susceptibility to all antibiotics tested was
established in a previous opinion (EFSA FEEDAP Panel, 2016). In that opinion, the FEEDAP
Panel concluded that the additive was safe for the target species, consumers and the environment.
The additive should be considered a potential respiratory sensitiser, but the Panel could not conclude
on the irritancy of the additive to skin and eyes or its dermal sensitisation. The Panel considers that
the proposed modifications to the terms of the authorisation of the additive will not introduce safety
concerns not already considered in the previous assessments.
6 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
7 Commission Implementing Regulation (EU) 2017/447 of 14 March 2017 concerning the authorisation of the preparation of
Bacillus subtilis (DSM 5750) and Bacillus licheniformis (DSM 5749) as a feed additive for sows, weaned piglets, pigs for
fattening, calves for rearing and turkeys for fattening and amending Regulations (EC) No 1453/2004, (EC) No 2148/2004 and
(EC) No 600/2005 (holder of authorisation Chr. Hansen A/S).
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3.3. Efficacy
3.3.1. Compatibility with coccidiostats
In previous opinions on the use of BioPlus® 2B in feed for chickens for fattening, the compatibility
of B. licheniformis DSM 5749 and B. subtilis DSM 5750 with maduramicin ammonium (EFSA, 2006),
semduramycin and formic acid (EFSA FEEDAP Panel, 2011) and lasalocid sodium (EFSA, 2008) at the
highest authorised levels for chickens for fattening was established. Data on the compatibility of one of
the strains (B. licheniformis DSM 5749) with monensin sodium was not available, while the
compatibility of both strains with diclazuril, halofuginone or robenidine hydrochloride was not
established (EFSA FEEDAP Panel, 2010).
During the course of the assessment, the applicant informed EFSA that the use of halofuginone
was not relevant in the current application and did not provide data on the compatibility with
halofuginone.
In the current application, the applicant provided in vitro studies to support the compatibility of the
active agents of Bioplus 2B® with diclazuril and robenidine hydrochloride and in vitro and in vivo
studies with monensin sodium. The in vitro study with monensin was not further assessed as no
information was provided on the minimum inhibitory concentrations (MIC)
The MIC for diclazuril and robenidine hydrochloride were assessed
The results indicate that Bioplus 2B® is compatible with diclazuril; for
robenidine hydrochlorides an in vivo study
would be required to support its compatibility. However such a study was not submitted.
One in vitro study and two in vivo studies were submitted to support the compatibility of the two
microbial strains with monensin sodium. However, the in vitro study did not report the MIC values
and therefore was not considered. Similarly, one of the in vivo studies was not considered
The remaining
in vivo study is described below.
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Conclusions on the compatibility previously drawn by the FEEDAP Panel for chickens for fattening
apply to the current application provided that the maximum authorised concentration of the
coccidiostats semduramycin, maduramicin ammonium, lasalocid sodium and the preservative formic
acid for turkeys for fattening (when maximum authorised concentrations exist), are equal or lower
than those for chickens for fattening.
Considering the data submitted, the FEEDAP Panel concludes that BioPlus® 2B (B. licheniformis
DSM 5749 and B. subtilis DSM 5750) is compatible with diclazuril and monensin sodium. Based on the
data provided, no conclusion can be drawn for robenidine hydrochloride. In the absence of data, no
conclusion can be drawn for halofuginone.
3.3.2. Post-market monitoring
The FEEDAP Panel considers that there is no need for specific requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation13 and Good
Manufacturing Practice.
4. Conclusions
The proposed modification in the conditions of the authorisation would not modify the conclusions
previously drawn regarding the safety of the additive. The additive is safe for the target species,
consumers and the environment. The additive should be considered a potential respiratory sensitiser, but
the Panel could not conclude on the irritancy of the additive to skin and eyes or its dermal sensitisation.
Conclusions previously drawn by the FEEDAP Panel on the compatibility of the additive for chickens
for fattening apply to the current application provided that the maximum authorised concentration of
the coccidiostats semduramycin, maduramicin ammonium, lasalocid sodium and the preservative
formic acid for turkeys for fattening (when maximum authorised concentrations exist), are equal or
lower than those for chickens for fattening.
Considering the data submitted, the FEEDAP Panel concludes that BioPlus® 2B (B. licheniformis
DSM 5749 and B. subtilis DSM 5750) is compatible with diclazuril and monensin sodium. Based on the
data provided, no conclusion can be drawn for robenidine hydrochloride. In the absence of data, no
conclusion can be drawn for halofuginone.
Chronology
Date Event
04/05/2017 Dossier received by EFSA. BioPlus® 2B (Bacillus licheniformis DSM 5749 and Bacillus subtilis DSM
5750) for turkeys for fattening. Chr. Hansen A/S.
13/08/2018 Dossier received by EFSA
28/08/2018 Reception mandate from the European Commission
09/10/2018 Application validated by EFSA – Start of the scientific assessment
06/10/2018 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientific assessment suspended. Issues: efficacy
09/01/2019 Comments received from Member States
01/03/2019 Reception of supplementary information from the applicant - Scientific assessment re-started
15/05/2019 Opinion adopted by the FEEDAP Panel. End of the Scientific assessment
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